$1.35
17.68% yesterday
Nasdaq, Sep 03, 10:15 pm CET
ISIN
US00808Y2081
Symbol
AEMD

Aethlon Medical, Inc. Stock price

$1.35
+0.14 11.57% 1M
-2.25 62.49% 6M
-5.53 80.38% YTD
-1.46 52.01% 1Y
-78.65 98.31% 3Y
-101.85 98.69% 5Y
-9,274.65 99.99% 10Y
-11,998.65 99.99% 20Y
Nasdaq, Closing price Wed, Sep 03 2025
-0.29 17.68%

Key metrics

Basic
Market capitalization
$3.5m
Enterprise Value
$-260.0k
Net debt
positive
Cash
$3.8m
Shares outstanding
2.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.0
P/B
1.0
Financial Health
Equity Ratio
69.6%
Return on Equity
-253.7%
ROCE
-231.3%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-8.2m | -
EBIT
$-8.5m | $-9.7m
Net Income
$-12.6m | $-5.0m
Free Cash Flow
$-7.6m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
28.8% | -
EBIT
28.2% | -3.4%
Net Income
-9.5% | 61.5%
Free Cash Flow
18.1%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-6.1
FCF per Share
$-2.9
Short interest
4.7%
Employees
14
Rev per Employee
$0.0
Show more

Is Aethlon Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Aethlon Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Aethlon Medical, Inc. forecast:

4x Hold
57%
3x Sell
43%

Analyst Opinions

7 Analysts have issued a Aethlon Medical, Inc. forecast:

Hold
57%
Sell
43%

Financial data from Aethlon Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 8.51 8.51
28% 28%
-
- Research and Development Expense - -
-
-
-8.18 -8.18
29% 29%
-
- Depreciation and Amortization 0.33 0.33
8% 8%
-
EBIT (Operating Income) EBIT -8.51 -8.51
28% 28%
-
Net Profit -13 -13
9% 9%
-

In millions USD.

Don't miss a Thing! We will send you all news about Aethlon Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Aethlon Medical, Inc. Stock News

Neutral
Seeking Alpha
21 days ago
Aethlon Medical, Inc. (NASDAQ:AEMD ) Q1 2026 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants James B. Frakes - CEO, CFO, Secretary & Director Steven P.
Neutral
PRNewsWire
21 days ago
Australian Cancer Trial Advances with First Cohort Complete, Amended Protocol, and Promising Preclinical Data Published; Operating Expenses Cut by 32% Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO , Aug. 13, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threat...
Neutral
PRNewsWire
30 days ago
SAN DIEGO , Aug. 5, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal first quarter ended June 30, 2025, at 4:15 p.m. ET on Wednesday, August 13, 2025.
More Aethlon Medical, Inc. News

Company Profile

Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.

Head office United States
CEO James Frakes
Employees 14
Founded 1991
Website www.aethlonmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today